HTG Molecular Diagnostics, Inc. Debt Securities, Available-for-sale, Current
HTG Molecular Diagnostics, Inc. had Debt Securities, Available-for-sale, Current of $3.57 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2023-05-11
- 2023-03-31: Debt Securities, Available-for-sale, Current $3.57M.
- 2022-12-31: Debt Securities, Available-for-sale, Current $0.00.
- 2022-09-30: Debt Securities, Available-for-sale, Current $3.32M.
- 2022-06-30: Debt Securities, Available-for-sale, Current $8.34M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2023-03-31 | $3.57M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-09-30 | $3.32M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $8.34M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $6.95M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $12.34M 10-K · filed 2023-03-30 |
| 2021-09-30 | $15.19M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $16.18M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $8.99M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $6.30M 10-K · filed 2022-03-29 |
| 2020-09-30 | $11.63M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $11.85M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $21.55M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $25.41M 10-K · filed 2021-03-25 |
| 2019-09-30 | $3.04M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $9.75M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $18.06M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $22.68M 10-K · filed 2020-03-25 |